BB&T Investment Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$1.24M Buy
46,490
+10,596
+30% +$269K 0.21% 115
2017
Q3
$865K Buy
35,894
+11,770
+49% +$266K 0.17% 121
2017
Q2
$514K Buy
24,124
+9,294
+63% +$188K 0.13% 147
2017
Q1
$258K Buy
14,830
+13,530
+1,041% +$236K 0.1% 174
2016
Q4
$24K Buy
+1,300
New +$23.6K 0.02% 393

Other funds holding NVO

BB&T Investment Services's NVO Position: Q4 2017 in Review

BB&T Investment Services increased its Novo Nordisk (NVO) stake by 30% in Q4 2017, buying an estimated $269K and bringing the position to 46,490 shares worth $1.24M. The position accounts for 0.21% of the portfolio, ranked #115.

BB&T Investment Services first reported a position in NVO in Q4 2016 and has held it in 5 quarters since. 552 funds tracked by Wall St. Rank hold NVO as of Q4 2017.

  • BB&T Investment Services held 46,490 shares of Novo Nordisk worth $1.24M as of Q4 2017.
  • BB&T Investment Services bought 10,596 Novo Nordisk shares in Q4 2017, an estimated $269K.
  • Novo Nordisk made up 0.21% of BB&T Investment Services's portfolio in Q4 2017, its #115 holding.
  • BB&T Investment Services first reported a position in Novo Nordisk in Q4 2016 and has held it in 5 quarters since.
  • 552 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.